Nippon India Pharma Fund vs Mirae Asset Healthcare Fund compare
Nippon India Pharma Fund-Growth Plan-Growth Option
Mirae Asset Healthcare Fund -Regular Growth
Chart Comparison
Overview
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Mirae Asset Healthcare Fund -Regular Growth |
---|---|---|
Fund | Nippon India Pharma Fund-Growth Plan-Growth Option | Mirae Asset Healthcare Fund -Regular Growth |
Investment Plan | Growth | Growth |
Level of Risk | Very High | Very High |
Asset Size (Cr) | ₹8161 Cr | ₹2652 Cr |
Min Investment | ₹5000 | ₹5000 |
Min SIP Invesment | ₹500 | ₹500 |
Min Addl Investment | ₹1000 | ₹1000 |
Launch Date | 05 Jun 2004 | 02 Jul 2018 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | BSE Healthcare | BSE Healthcare |
Turn Over | 21% | 15% |
Expense Ratio | 1.82 | 1.92 |
Manager | Sailesh Raj Bhan | Vrijesh Kasera |
ISIN Code | INF204K01968 | INF769K01EA2 |
Exits Load | Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 | Mirae Asset Healthcare Fund - Growth charges 1.0% of sell value; if fund sold before 365 days. There are no other charges./365 |
Trailing Lumpsum Returns
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Mirae Asset Healthcare Fund -Regular Growth |
---|---|---|
1 Month | 1.79% | 1.5% |
6 Month | -1.2% | -2.12% |
1 Year | 12.25% | 14.23% |
3 Year | 25.83% | 24.23% |
5 Year | 21.65% | 21.68% |
SIP Return Analysis
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Mirae Asset Healthcare Fund -Regular Growth |
---|---|---|
6 Month | 6.59% | 5.36% |
1 Year | 8.53% | 6.12% |
3 Year | 24.42% | 23.7% |
5 Year | 19.8% | 19.12% |
Rolling Lumpsum Returns
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Mirae Asset Healthcare Fund -Regular Growth |
---|---|---|
1 Year | 17.67% | 22.82% |
3 Year | 20.32% | 18.76% |
5 Year | 20.52% | 24.22% |
Risk Management
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Mirae Asset Healthcare Fund -Regular Growth |
---|---|---|
Standard Deviation | 15.623% | 16.629% |
Sharp | 0.707% | 0.604% |
Beta | 0.908% | 0.974% |
Alpha | 0.486% | -1.264% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
Fund Managers
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Mirae Asset Healthcare Fund -Regular Growth |
---|---|---|
Name | Sailesh Raj Bhan | Vrijesh Kasera |
Total AUM | ₹96086 Cr | ₹12061 Cr |
Funds Managed | 5 | 4 |
Nippon India Pharma Fund-Growth Plan-Growth Option | Mirae Asset Healthcare Fund -Regular Growth |
Market Cap
Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
Mirae Asset Healthcare Fund -Regular Growth |
---|---|---|
Others | 1.36 | 2.93 |
Large Cap | 38.72 | 34.72 |
Mid Cap | 32.78 | 39.03 |
Small Cap | 27.14 | 23.32 |
Sector Allocation
Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
Mirae Asset Healthcare Fund -Regular Growth |
---|---|---|
Others | 1.36 | 0.17 |
Healthcare | 98.64 | 98.36 |
Basic Materials | - | 0.74 |
Industrials | - | 0.73 |
Top Comparisons
Sundaram Equity Savings Fund (G)
3Y Returns13.43%
Sundaram Equity Savings Fund (Formerly Known as Principal Equity Savings Fund) - Direct Plan - Growth Option
3Y Returns15.32%
ICICI Prudential Silver ETF Fund of Fund - Growth
3Y Returns19.23%
Axis Silver Fund of Fund -Regular Plan- Growth Option
3Y Returns0%
Kotak Low Duration Fund- Regular Plan-Growth Option
3Y Returns7.09%
SBI Magnum Low Duration Fund - Regular Plan - Growth
3Y Returns7%
HDFC Non-Cyclical Consumer Fund - Regular (G)
3Y Returns0%
Mirae Asset Great Consumer Fund - Regular Plan - Growth option
3Y Returns22.48%